- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04026386
A Center Based Early Intervention Program For Preschoolers With Developmental Disorders
The purpose of this study is to examine the effectiveness of a 12-week early intervention program that will include 12 weekly hours in an intensive center-based preschool environment or in the home to treat social communication deficits in children with developmental disorders. The study will include children with developmental disorders, such as Autism Spectrum Disorder, neurogenetic disorders, or intellectual disability.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Robin Libove, BS
- Phone Number: (650) 736-1235
- Email: rlibove@stanford.edu
Study Contact Backup
- Name: Beatrice Begley, BS
- Phone Number: (650) 736-1235
- Email: PALprogram@stanford.edu
Study Locations
-
-
California
-
Stanford, California, United States, 94305
- Recruiting
- Stanford University School of Medicine
-
Principal Investigator:
- Antonio Hardan, MD
-
Contact:
- Beatrice Begley, BS
- Phone Number: 650-736-1235
- Email: PALprogram@stanford.edu
-
Contact:
- Ellen Choi, BS
- Phone Number: (650) 736-1235
- Email: PALprogram@stanford.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Diagnosis of Developmental Disorder, such as Autism Spectrum Disorder, neurogenetic disorder, or intellectual disability, based on clinical interview;
- Boys and girls between 2.0 years and 5.11 years at time of enrollment;
- Ability to participate in the testing procedures to the extent that valid standard scores can be obtained.
Exclusion Criteria:
- Current or lifetime diagnosis of severe psychiatric disorder (e.g., bipolar disorder, etc.);
- Lack of availability during program hours.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Center Based or In-Home Early Intervention Program
|
This is a 12-week early intervention program that will include 12 weekly hours of treatment in an intensive center-based preschool environment or in home to treat social communication deficits in children with developmental disorders. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change From Baseline in Parent Rated Social Responsiveness Scale, 2nd Edition (SRS-2) T-Score After Treatment.
Time Frame: Baseline, 12 Weeks
|
Social Responsiveness Scale, 2nd Edition (SRS) scores measure social abilities with lower scores meaning better social abilities. (T-Score Range: 37- above 90 ) |
Baseline, 12 Weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change From Baseline in Parent Rated Vineland Adaptive Behavior Scale- 3 (VABS-3) Scores During Treatment.
Time Frame: Baseline, 12 Weeks
|
Baseline, 12 Weeks
|
|
|
Change From Baseline in Parent Rated Short Sensory Profile Questionnaire (SSPQ) Scores During Treatment.
Time Frame: Baseline, 12 Weeks
|
Baseline, 12 Weeks
|
|
|
Change From Baseline in Parent Rated General Self Efficacy Scale (GSES) Scores During Treatment.
Time Frame: Baseline, 12 Weeks
|
Baseline, 12 Weeks
|
|
|
Change From Baseline in Parent Rated Repetitive Behavior Scale Revised (RBS-R) Scores During Treatment.
Time Frame: Baseline, 12 Weeks
|
Higher scores on the Repetitive Behavior Scale- Revised mean higher levels of repetitive and restricted behaviors. (Raw Score Total Range: 0 - 129) |
Baseline, 12 Weeks
|
|
Change From Baseline in Parent Rated Stanford Social Dimension Scale (SSDS) Scores During Treatment.
Time Frame: Baseline, 12 Weeks
|
Higher Scores on the Stanford Social Dimension Scale mean better social functioning and lower scores mean worse social functioning (Range: 58-290). |
Baseline, 12 Weeks
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Antonio Hardan, MD, Stanford University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Neurologic Manifestations
- Nervous System Diseases
- Mental Disorders
- Neurobehavioral Manifestations
- Neurodevelopmental Disorders
- Child Development Disorders, Pervasive
- Communication Disorders
- Pathological Conditions, Signs and Symptoms
- Signs and Symptoms
- Autism Spectrum Disorder
- Developmental Disabilities
- Learning Disabilities
Other Study ID Numbers
- IRB-52348
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.